FIRST MANHATTAN CO. LLC. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 316 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$29,534,267
-24.6%
1,099,1540.0%0.11%
-24.3%
Q2 2023$39,195,831
+50.5%
1,099,154
+7.2%
0.14%
+44.0%
Q1 2023$26,051,611
-37.4%
1,025,6540.0%0.10%
-34.2%
Q4 2022$41,600,526
+13.9%
1,025,654
-7.2%
0.15%
-1.9%
Q3 2022$36,539,000
-6.2%
1,105,587
-0.1%
0.16%
-1.3%
Q2 2022$38,965,000
-24.9%
1,106,662
-1.9%
0.16%
-7.6%
Q1 2022$51,879,000
-30.6%
1,128,0620.0%0.17%
-30.9%
Q4 2021$74,790,000
+6.0%
1,128,062
-0.2%
0.25%
-5.4%
Q3 2021$70,568,000
-24.8%
1,130,363
-0.3%
0.26%
-24.2%
Q2 2021$93,881,000
+24.9%
1,133,563
+0.0%
0.34%
+5.9%
Q1 2021$75,145,000
-21.7%
1,133,246
-9.4%
0.32%
-29.4%
Q4 2020$95,940,000
+41.2%
1,250,369
-20.8%
0.46%
+31.1%
Q3 2020$67,969,000
-0.3%
1,578,4730.0%0.35%
-11.2%
Q2 2020$68,174,000
+46.6%
1,578,473
-2.3%
0.39%
+30.9%
Q1 2020$46,492,000
-64.6%
1,616,023
-21.9%
0.30%
-54.3%
Q4 2019$131,174,000
+54.0%
2,068,020
-31.6%
0.66%
+40.3%
Q3 2019$85,169,000
+4.4%
3,022,325
-1.9%
0.47%
+3.5%
Q2 2019$81,615,000
-9.7%
3,079,825
-37.4%
0.45%
-13.2%
Q1 2019$90,346,000
+44.7%
4,923,525
-2.1%
0.52%
+34.2%
Q4 2018$62,436,000
-35.6%
5,027,125
-0.5%
0.39%
-24.6%
Q3 2018$96,883,000
+57.2%
5,053,925
+11.6%
0.52%
+45.4%
Q2 2018$61,611,000
+88.6%
4,530,2500.0%0.36%
+90.9%
Q1 2018$32,663,000
+179.0%
4,530,250
+42.4%
0.19%
+190.6%
Q4 2017$11,707,0003,181,3500.06%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders